204 related articles for article (PubMed ID: 21491453)
21. Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.
Khattab IS; Nada A; Zaghloul AA
Drug Dev Ind Pharm; 2010 Aug; 36(8):893-902. PubMed ID: 20196643
[TBL] [Abstract][Full Text] [Related]
22. Development of PVP/PEG mixtures as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique and optimization of dissolution using artificial neural networks.
Barmpalexis P; Koutsidis I; Karavas E; Louka D; Papadimitriou SA; Bikiaris DN
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1219-31. PubMed ID: 23541514
[TBL] [Abstract][Full Text] [Related]
23. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
25. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
Samy AM; Marzouk MA; Ammar AA; Ahmed MK
Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.
Suhagia BN; Patel HM; Shah SA; Rathod I; Parmar VK
Acta Pharm; 2006 Sep; 56(3):285-98. PubMed ID: 19831278
[TBL] [Abstract][Full Text] [Related]
28. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
Gorajana A; Kit WW; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
[TBL] [Abstract][Full Text] [Related]
29. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
30. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.
Karavas E; Ktistis G; Xenakis A; Georgarakis E
Drug Dev Ind Pharm; 2005 Jul; 31(6):473-89. PubMed ID: 16109621
[TBL] [Abstract][Full Text] [Related]
31. Benznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers.
Soares-Sobrinho JL; Santos FL; Lyra MA; Alves LD; Rolim LA; Lima AA; Nunes LC; Soares MF; Rolim-Neto PJ; Torres-Labandeira JJ
Carbohydr Polym; 2012 Jun; 89(2):323-30. PubMed ID: 24750726
[TBL] [Abstract][Full Text] [Related]
32. Formulation and characterization of glipizide solid dosage form with enhanced solubility.
Alotaibi BS; Khan MA; Ullah K; Yasin H; Mannan A; Khan SA; Murtaza G
PLoS One; 2024; 19(2):e0297467. PubMed ID: 38394326
[TBL] [Abstract][Full Text] [Related]
33. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
34. Effect of Sulindac Binary System on In Vitro and In Vivo Release Profiles: An Assessment of Polymer Type and Its Ratio.
Shazly GA
Biomed Res Int; 2016; 2016():3182358. PubMed ID: 27840824
[TBL] [Abstract][Full Text] [Related]
35. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ
Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
[TBL] [Abstract][Full Text] [Related]
36. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
Puri V; Dantuluri AK; Bansal AK
J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of dissolution profile by solid dispersion (kneading) technique.
Modi A; Tayade P
AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249
[TBL] [Abstract][Full Text] [Related]
38. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
Wu K; Li J; Wang W; Winstead DA
J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575
[TBL] [Abstract][Full Text] [Related]
39. Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs.
Fael H; Ràfols C; Demirel AL
J Pharm Sci; 2018 Sep; 107(9):2428-2438. PubMed ID: 29859957
[TBL] [Abstract][Full Text] [Related]
40. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
